Phase 2 Data: The Evidence That Set Expectations The Phase 2 trial of retatrutide in adults with obesity, published in The New England Journal of Medicine in 2023, enrolled 338 participants across multiple dose cohorts and a placebo arm over 48 weeks [1]
It plays an important role in detoxing the liver and protecting its sulfur-rich antioxidant pathways [53, 54, 55]
But each pharmacy has their own proprietary blend and may have different ingredients or strengths
But because theyre mostly anecdotal, its difficult to know whats truly caused by the compound, how common these effects are, or how much is tied to product quality or dosing variability
This question echoes in the minds of many health enthusiasts, as timing and method can significantly impact the effectiveness of any supplement
This helps increase feelings of fullness and supports weight loss